Ra Pharmaceuticals Inc (RARX) Annual Balance Sheets

Annual · GAAP · USD millions
Access RARX quarterly Balance Sheets →
From Ra Pharmaceuticals Inc through , shifts in Dec 31 2019's assets and liabilities provide insight into the company's capital structure and financial stability.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2019)
(Dec 31 2018) (Dec 31 2017) (Dec 31 2015)
Assets
Cash & cash equivalent264.99
Cash & Short-term Investments264.00
Accounts receivable0.00
Prepaid Expense And Other Assets Current9.70
Total Current Assets274.69
Equipment/Property/Plant Net4.73
Goodwill net0.00
Intangible Assets0.00
Long-term investments1.33
Tax Assets, Noncurrent0.00
Other Assets, Noncurrent3.39
Total Assets284.15
Liabilities
Accounts Payable, Current AC1.82
Accrued Liabilities, Current AC15.18
Other Liabilities, Current1.58
Deferred Liability and Revenue0.00
Total Current Liabilities18.58
Total Long-term Debt0.00
Deferred credits, Noncurrent0.00
Accrued Income Taxes, Noncurrent0.00
Other liabilities, Noncurrent3.46
Deferred Income Tax Liabilities Net0.00
Total Liabilities22.04
Stockholders' Equity
Common Stock Value0.05
Additional Paid In Capital Common Stock552.91
Retained Earnings / Accumulated Deficit-290.85
Other Equity0.00
Common Stockholder's Equity262.11
Total Stockholder's Equity262.11
Liabilities & Stockholder's Equity284.15
4 historic quarters locked

Sign in to unlock the full Ra Pharmaceuticals Inc balance sheet history.

About RARX Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License